Substance / Medication

Delavirdine

Overview

Active Ingredient
delavirdine
RxNorm CUI
83816

Indications & Related Conditions

Conditions associated via SNOMED clinical relationships

Administration & Protocol

Dosing, route, and treatment protocol

Administration details including route, dosing schedules, preparation instructions, and contraindications are pending physician authorship.

Monitoring & Follow-Up

Biomarkers relevant to this intervention via related conditions

No monitoring biomarkers have been mapped yet. Biomarker-intervention linkages are derived through related conditions and will expand as the knowledge graph grows.

Research Evidence

Published studies and systematic reviews

Sort:
Rhabdomyolysis with acute renal failure probably related to the interaction of atorvastatin and delavirdine.
Castro Jose G, Gutierrez Luis · Am J Med · 2002
PMID: 11959068Case Report
Hybrids of delavirdine and piperdin-4-yl-aminopyrimidines (DPAPYs) as potent HIV-1 NNRTIs: Design, synthesis and biological activities.
Ming Wei, Lu Wen-Long, Pannecouque Christophe et al. · Eur J Med Chem · 2023
PMID: 36640458Other
Interactions between buprenorphine and antiretrovirals. I. The nonnucleoside reverse-transcriptase inhibitors efavirenz and delavirdine.
McCance-Katz Elinore F, Moody David E, Morse Gene D et al. · Clin Infect Dis · 2006
PMID: 17109309Other
Delavirdine modifies action potential configuration via inhibition of Iand Iin canine ventricular myocytes.
Óvári József, Kovács Zsigmond Máté, Dienes Csaba et al. · Biomed Pharmacother · 2025
PMID: 40120556Preclinical
Population pharmacokinetics of delavirdine and N-delavirdine in HIV-infected individuals.
Smith Patrick F, Dicenzo Robert, Forrest Alan et al. · Clin Pharmacokinet · 2005
PMID: 15634033Trial

Research data from MEDLINE/PubMed

Benefits & Expected Outcomes

Benefits, expected outcomes, efficacy data, and NNT (Number Needed to Treat) are pending physician authorship and evidence review.

Risks & Side Effects

Risk profile, common and serious adverse effects, contraindications, and drug interactions are pending physician authorship.

Related Symptoms

Symptoms associated with conditions this intervention addresses

No related symptoms have been mapped yet. Symptom linkages are derived through associated conditions.

Alternatives & Comparisons

Alternative treatments, comparison data, and clinical decision support are pending physician authorship.

Medical Disclaimer

This information is for educational purposes only and does not constitute medical advice, diagnosis, or treatment. Always consult with a qualified healthcare provider regarding any medical condition or treatment plan.

Do not start, stop, or change any treatment without consulting your healthcare provider.

Quick Facts

Type
Substance / Medication
Fully Specified Name
Delavirdine (substance)
SNOMED CT
108710001
UMLS CUI
C0288165
RxNorm CUI
83816

Clinical Data

This intervention maps to 2 entities in the Healos knowledge graph.

2
Conditions
0
Biomarkers
0
Specialists
0
Symptoms

Data is sourced from SNOMED CT, UMLS, and the Healos clinical knowledge graph. Content sections marked as pending require physician authorship. Consult a healthcare provider before starting any treatment.